China National Pharmaceutical Group Corporation (600420.SH): Obtained drug registration certificates for Nalbuphine Hydrochloride Injection and Hydroxychloroquine Sulfate Tablets.

Zhijing Finance App News, China National Pharmaceutical Group Corporation (600420.SH) announced that its subsidiaries, China National Pharmaceutical Group Industrial Co., Ltd. (referred to as China National Pharmaceutical Group Industrial) and China National Pharmaceutical Group Chuan Kang Pharmaceutical Co., Ltd. (referred to as China National Pharmaceutical Group Chuan Kang), have recently received the Drug Registration Certificates issued by the National Medical Products Administration for the hydrochloride nalbuphine injection and hydroxychloroquine sulfate tablets, respectively.